Favorite | Set Homepage | Look Around

Simcere pharmaceutical

Simcere has swiftly evolved from a pure pharmaceutical distributor into a leading pharmaceutical manufacturer and supplier in China's rapidly growing pharmaceutical market.

www.cphibiz.com
News
  • no record
Type
  • no record
Search
 
link
  • no record
Current Location:Home » Welcome
Elite
Cefterampivoxil

2021-05-06

Benazepril HCI

2021-05-06

Valaciclovir HCI

2021-05-06

Ondansetron HCI

2021-05-06

Oxaliplatin

2021-05-06

Eapidil

2021-05-06

Aldioxa

2021-05-06

Amlodipine Maleate

2021-05-06

company profile
 Founded on 28th March 1995, Simcere has swiftly evolved from a pure pharmaceutical distributor into a leading pharmaceutical manufacturer and supplier in China's rapidly growing pharmaceutical market. Simcere currently operates one research and development center, two nationwide sale and marketing subsidiaries and four GMP manufacturing facilities. It has approximately 4,300 employees in China. 

Innovation is the key driver of our growth towards excellence. In recent years, we have refined our strategy to focus on innovative pharmaceuticals and first-to-market generics.
Simcere's sales and marketing network has established a deep market penetration and broad coverage across China. Our current portfolio is comprised of innovative pharmaceuticals, first-to-market generics and branded generics in five core disease areas ¨C oncology, neurology, cardiovascular/cerebrovascular, inflammation and infectious diseases, reflected in 50+ product combinations.Innovation is the key d... [Introduce]
Sell
Cefterampivoxil

2021-05-06

Benazepril HCI

2021-05-06

Valaciclovir HCI

2021-05-06

Ondansetron HCI

2021-05-06

Oxaliplatin

2021-05-06

Eapidil

2021-05-06

Aldioxa

2021-05-06

Amlodipine Maleate

2021-05-06